Vascular anomalies and interventions
Vascular anomalies and interventions is a research topic within Surgery. Science Explorer counts 23k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on a wide range of venous anomalies and syndromes in the vascular system, including anomalies of the inferior vena cava, superior mesenteric artery syndrome, nutcracker syndrome, vascular compression syndromes, and venous aneurysms. The papers discuss the diagnosis, imaging findings, clinical implications, treatment strategies, and surgical interventions for these venous abnormalities.
- Inferior Vena Cava
- Superior Mesenteric Artery Syndrome
- Nutcracker Syndrome
- Vascular Anomalies
- Deep Vein Thrombosis
- Left Superior Vena Cava
- Renal Nutcracker Syndrome
- Vascular Compression Syndromes
- Venous Aneurysms
- Congenital Venous Abnormalities
- Research works
- 23k fractional, since 1950
- In the world top 10%
- 2.3k per year above
- Top-10% rate
- 10.1% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +10% the tick is no change
- Largest producer
United States
36% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Vascular anomalies and interventions research?
By volume, the United States and India publish the most (977 and 393 works in 2022-now).
By volume, 2022-now
- 1
United States 977 works
- 2
India 393 works
- 3
China 384 works
- 4
Japan 270 works
- 5
Türkiye 151 works
- 6
Italy 144 works
- 7
United Kingdom 109 works
- 8
Brazil 101 works
- 9
Germany 99 works
- 10
Spain 96 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Vascular anomalies and interventions research?
By volume in 2022-now, All India Institute of Medical Sciences publishes the most Vascular anomalies and interventions research, followed by Mayo Clinic and Harvard University.
By volume, 2022-now
- 1
All India Institute of Medical Sciences
India 58 works
- 2
Mayo Clinic
United States 32 works
- 3
Harvard University
United States 32 works
- 4
Sichuan University
China 21 works
- 5
Cleveland Clinic
United States 17 works
- 6
Capital Medical University
China 17 works
- 7
Mount Sinai Health System
United States 16 works
- 8
Yale University
United States 16 works
- 9
Post Graduate Institute of Medical Education and Research
India 15 works
- 10
Shanghai Jiao Tong University
China 14 works
Who are the leading researchers in Vascular anomalies and interventions?
The most-cited researchers publishing on Vascular anomalies and interventions include Stephan Windecker, Gregory Y.H. Lip and Victoria Delgado.
- 1
Stephan Windecker
Switzerland 338k citations
- 2
Gregory Y.H. Lip
United Kingdom 311k citations
- 3
Victoria Delgado
Netherlands 269k citations
- 4
Marcello A. Tonelli
Canada 268k citations
- 5
Valentı́n Fuster
United States 257k citations
- 6
Patrizio Lancellotti
Belgium 245k citations
- 7
Deepak L. Bhatt
United States 227k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Vascular anomalies and interventions research done?
The largest centres of Vascular anomalies and interventions research in 2022-now are New Delhi (India), Tokyo (Japan), Istanbul (Türkiye) and Beijing (China).
Largest cities, 2022-now
- 1
New Delhi
India 59 works
- 2
Tokyo
Japan 53 works
- 3
Istanbul
Türkiye 51 works
- 4
Beijing
China 50 works
- 5
New York
United States 43 works
- 6
Mexico City
Mexico 42 works
- 7
Moscow
Russia 36 works
- 8
London
United Kingdom 34 works
- 9
Boston
United States 33 works
- 10
Philadelphia
United States 32 works
Where is the best place to study Vascular anomalies and interventions?
Among universities, judged by research, Pirogov Russian National Research Medical University, Harvard University and All India Institute of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Vascular anomalies and interventions, country by countryIs Vascular anomalies and interventions research growing?
Output in 2022-2025 was 10% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Vascular anomalies and interventions.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Vascular anomalies and interventions as a percentage of every work published that year, 0.018% in 2024.
Fractional works of Vascular anomalies and interventions over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Vascular anomalies and interventions. Posts are plain text and can be reported.